Boehringer Ingelheim
Last updated on 2013-11-20T06:39+0300.
About this
image
License:
UNKNOWN
| Key Titles and Phrases | Count | Lang | Last Seen |
|---|---|---|---|
| farmacêutica alemã | 40.00% | PT | 29/12/2016 |
| farmacêutica | 20.00% | PT | 24/05/2016 |
| manufacturer | 20.00% | EN | 23/03/2015 |
| german manufacturer | 20.00% | EN | 23/03/2015 |
| Names | Lang | Count |
|---|---|---|
| Boehringer Ingelheim | EN | 61.60% |
| Boehringer Ingelheim | FR | 14.81% |
| Boehringer Ingelheim Pharmaceuticals | EN | 3.55% |
| Boehringer Ingelheim | PT | 3.10% |
| Boehringer Ingelheim | ES | 2.34% |
| Boehringer Ingelheim | PL | 2.19% |
| Boehringer Ingelheim | DE | 2.19% |
| Boehringer Ingelheim | IT | 2.12% |
| Boehringer Ingelheim | EU | 2.04% |
| Boehringer Ingelheim | SV | 2.04% |
| Boehringer-Ingelheim | EN | 1.74% |
| Boehringer-Ingelheim | FR | 1.51% |
| Boehringer-Ingelheim Pharmaceuticals | EN | 0.23% |
| Boehringer Ingelheim | AR | 0.15% |
| BOEHRINGER INGELHEIM | EN | 0.08% |
| Boehringer-Ingelheim Pharmaceuticals | FR | 0.08% |
| Boehringer Ingelheim Pharmaceuticals | PT | 0.08% |
| Boehringer Ingelheim Pharmaceuticals | ES | 0.08% |
| Boehringer-Ingelheim | DE | 0.08% |
| ベーリンガーインゲルハイム | JA | 0.00% |
| 勃林格殷格翰 | ZH | 0.00% |
| Type | Entity Name | Count |
|---|---|---|
 | Inc | 5.88% |
| Novartis | 3.65% |
| Pfizer Inc | 3.65% |
| Eli Lilly | 3.04% |
| GlaxoSmithKline | 2.74% |
| World Health Organization | 2.13% |
| Bristol Myers Squibb | 2.03% |
| Novo Nordisk | 1.62% |
| Teva Pharmaceuticals | 1.52% |
 | Association | 1.32% |
| Drug Administration | 1.32% |
| Pharmaceuticals Inc | 1.22% |
| European Society | 1.01% |
| Commission | 1.01% |
| Roche Holding AG | 1.01% |
| Laura Wood | 0.91% |
| Cancer Research | 0.91% |
| European Union | 0.91% |
| Five Forces | 0.81% |
| Solutions | 0.81% |
| Merck Sharp | 0.81% |
| SA | 0.81% |
| Clinical Development | 0.71% |
| GlaxoSmithKline Plc | 0.71% |
| Ali Yousef | 0.71% |
| chrysler | 0.71% |
| Alfa Romeo | 0.71% |
| Philip Morris International | 0.71% |
| Fiat | 0.71% |
| Altria Group Inc | 0.71% |
| Type | Entity Name | Score |
|---|---|---|
| Didier Jambart | 0.1429 |
| Økonomisk Ugebrev | 0.0588 |
| Novartis | 0.0348 |
| Eli Lilly | 0.0309 |
| Pfizer Inc | 0.026 |
| Milton Packer | 0.023 |
| GlaxoSmithKline | 0.0227 |
| Bristol Myers Squibb | 0.0184 |
| Novo Nordisk | 0.0161 |
| Teva Pharmaceuticals | 0.014 |
| Annalisa Jenkins | 0.0135 |
| Pharmaceuticals Inc | 0.0114 |
| Alexis Peyroles | 0.0106 |
| Inc | 0.0104 |
| European Society | 0.0099 |
| Roche Holding AG | 0.0093 |
| Green Cross Corp | 0.0087 |
| Cancer Research | 0.0086 |
| Merck Sharp | 0.0082 |
| Drug Administration | 0.008 |
| Laura Wood | 0.0079 |
| Altria Group Inc | 0.0076 |
| Philip Morris International | 0.0073 |
| Toni K Choueiri | 0.0071 |
| Energy Drink | 0.007 |
| Clinical Development | 0.0069 |
| Alfa Romeo | 0.0069 |
| GlaxoSmithKline Plc | 0.0068 |
| Five Forces | 0.0067 |
| Cord Dohrmann | 0.0063 |
Show/hide duplicate news articles.
Show/hide duplicate news articles.
Tools
Thursday, October 1, 2020
8:47:00 AM EAT
Languages 
Select your languages
Explore Relations
Please send any comments or suggestions to 